OverviewAltoida, a leader in neurological diagnostics, employs augmented reality (AR) and machine learning (ML) to develop digital biomarkers for early detection and monitoring of neurodegenerative diseases, particularly Alzheimer's. Their platform…
A digital cognitive assessment platform to support early detection of Alzheimer’s and other dementias and intervention in brain health. Description Uses a proprietary assessment technology DCTclock to test for for…
Drug Name: Leqembi Indications: To treat Alzheimer’s disease Active Ingredient: Lecanemab-irmb Company: Eisai Inc Approval Date: 1/6/2023 More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761269Orig1s000lbl.pdf